Beetroot Powder

Dietary nitrate-rich powder that elevates NO for enhanced perfusion and oxygenation in hypoxic tumors; betalains provide antioxidant/anti-inflammatory support; preclinical signals for chemoprevention and therapy adjunct.

← All agents

Catalog entry human-reviewed · each study below is labeled with how it was published · How we review →

AI extractedhuman reviewedsources checkedretractions suppressed

Get cited updates on Beetroot Powder

A monthly email when the research changes — $10/mo. Manage follows

Follow Beetroot Powder

🔬⭐⭐ Preliminary — Human physiology data for perfusion; anticancer signals mainly preclinical.Beet powderRed beetroot powderBeta vulgaris powder

Forms: Beetroot powder (loose or capsules, 1–5 g per serving)

Educational only, not medical advice. OncoForge makes no claim that Beetroot Powder treats, prevents, or cures any condition, beyond what the linked studies show. Evidence levels vary; effects may not translate to people, and some compounds can cause harm. Always coordinate with your oncology team.

Simple Summary

By raising nitric oxide, beetroot can widen blood vessels and improve tissue oxygenation—potentially helping radiation and some drugs in hypoxic tumors. Its pigments (betalains) add antioxidant/anti-inflammatory support. Consider it as supportive care; anticancer effects are mostly preclinical.

Evidence at a glance

Tier 2 · animalColorectalBreastProstateVarious (preclinical)

Preliminary — Human physiology data for perfusion; anticancer signals mainly preclinical/in vitro, with chemopreventive and protective effects during treatment.

How it may work

Beetroot is rich in dietary nitrates that convert to nitric oxide (NO), a vasodilator that can increase tissue blood flow and oxygenation. Improved oxygen delivery may enhance sensitivity to radiation and some chemotherapies in hypoxic tumors. Beetroot’s betalain pigments have strong antioxidant and anti-inflammatory activity, reducing lipid peroxidation and related signaling. NO donors also modulate tumor biology, including immune responses, in preclinical models.

Targets & pathways

Curated mechanistic targets reported for this agent — how it may act on cells, not proof of a clinical effect.

Nitric Oxide (NO) production↑Via dietary nitrates conversion to NO
Vasodilation / Tissue Perfusion↑
Tissue Oxygenation↑May enhance sensitivity to radiation/chemotherapy in hypoxic tumors
Oxidative Stress↓Via betalain antioxidants reducing lipid peroxidation
Inflammation↓Anti-inflammatory activity from betalains
Tumor Immune ResponseModulationNO donors alter antitumor immunity in preclinical models

NO DonorPerfusionOxidative Stress Modulation

Often studied / combined with

Combinations reported in the literature, not a protocol or a recommendation.

Radiation: Better oxygenation increases radiosensitivity.
HBOT / High-O₂ strategies: Complementary oxygen delivery and utilization.
Exercise: Enhances nitrate-to-NO conversion and perfusion.

Overlapping mechanisms

NO Donor ↑: Avoid combining with other nitrate sources (e.g., spinach, arugula) to prevent excessive BP drop.

Safety & interactions

Severity and how well-established each signal is are shown separately. Verify everything with your oncologist or pharmacist — absence here does not mean safe.

Risk categories

Gi Upset MildBeeturia HarmlessOxalate RiskHypotension Risk MildMetal Accumulation

Potential interactions

PDE5 inhibitors (e.g., sildenafil)MonitorModerateTheoreticalAdditive NO effects may cause hypotension.
Antihypertensive medicationsMonitorMinorTheoreticalPotential additive blood pressure lowering.
Radiation therapy / ChemotherapyConsiderBeneficialTheoreticalMay enhance efficacy via improved oxygenation in hypoxic tumors.

Timing

AM / Pre-activity: For peak NO boost; or 2–3 hours before radiation/exercise.
Divided doses: To sustain NO levels throughout the day.

References

Research

No published studies for Beetroot Powder yet

New studies appear here once they’ve been reviewed. Browse all studies.

Dose: as studied, not a recommendation

These are doses as studied or reported, never a recommendation. The right amount of Beetroot Powder depends on you, your other medicines, and your situation; decide it with your oncology team and pharmacist, not from a web page.

Ranges seen in adjunct / practice use: 5–20 g (po) Once or divided daily. Based on human physiology trials (e.g., 10–20 g in safety studies) and scaled preclinical data (HED ~40–80 mg/kg from rat 250–500 mg/kg extract doses, equating to 2.4–4.8 g for 60 kg human, adjusted higher for whole powder) for adjunct support in hypoxia/radiation settings., No Rx required. Nitrate content varies (aim for 300–600 mg nitrate equivalent); start low for GI tolerance. Oncology use as supportive—consult clinician..

Trials studying Beetroot Powder

No actively-recruiting trials matched right now. Recruiting is not the same as proven. Search ClinicalTrials.gov →

Inclusion here is not an endorsement. OncoForge makes no claim beyond what the linked studies show. Discuss anything on this page with your oncology team before acting on it.

← All agents · Research Radar